Organic-inorganic composites for bone drug delivery

AAPS PharmSciTech

Volumn 10, Issue 4, 2009, Pages 1158-1171

  Soundrapandian, Chidambaram ^a   Sa, Biswanath ^a   Datta, Someswar ^b  

^a JADAVPUR UNIVERSITY   (India)

^b CSIR CENTRAL GLASS AND CERAMIC RESEARCH INSTITUTE   (India)

Author keywords

Biomaterials; Carrier systems; Composite; Local delivery; Organic inorganic

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BIOCERAMICS; BONE MORPHOGENETIC PROTEIN; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE DIBASIC; CALCIUM SILICATE; CALCIUM SULFATE; CEFTRIAXONE; DRUG CARRIER; GLASS; GROWTH FACTOR; HYDROXYAPATITE; IBUPROFEN; INORGANIC COMPOUND; MACROGOL; NONSTEROID ANTIINFLAMMATORY AGENT; ORGANIC COMPOUND; POLY(METHYL METHACRYLATE); POLYGLACTIN; POLYMER; RISEDRONIC ACID; SOMATOMEDIN; TITANIUM; TRANSFORMING GROWTH FACTOR; UNINDEXED DRUG; ZIRCONIUM;

ARTHRITIS; BONE; BONE INFECTION; BONE REGENERATION; COMPOSITE MATERIAL; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG RESEARCH; HUMAN; LIVER TOXICITY; NEPHROTOXICITY; OSTEOARTHRITIS; POSTOPERATIVE PAIN; REVIEW;

ANIMALS; ANTI-BACTERIAL AGENTS; BIODEGRADATION, ENVIRONMENTAL; BIOMECHANICS; BONE AND BONES; DRUG DELIVERY SYSTEMS; EMULSIONS; FREEZE DRYING; GROWTH SUBSTANCES; HUMANS; PHASE TRANSITION; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; VOLATILIZATION;

EID: 75549089514     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9308-0     Document Type: Review

References (78)

1. MJ Gardner D Demetrakopoulos MK Shindle MH Griffith JM Lane 2006 Osteoporosis and skeletal fractures HSS J 2 1 62 69 10.1007/s11420-005-0137-8 18751849 (Pubitemid 44421783)
2. Gururaj G. Injuries in India: national perspective burden of disease in India. In: NCoMaH, editor. Government of India; 2005. pp. 325-47.
3. Kavarthapu V. (2009) Available from: http://orthosurgeon.org.uk/hip- aurthoplast.html. Accessed 2009 July 25.
4. MK Benson SP Hughes 1975 Infection following total hip replacement in a general hospital without special orthopaedic facilities Acta Orthop Scand 46 968 978 1:STN:280:DyaE287gvVGjug%3D%3D 813492
5. R Chung BA Bivins 1991 Antimicrobial prophylaxis in surgery. A synopsis Infect Dis Newsl 10 1 4 10.1016/0278-2316(91)90024-T
6. Grogan TJ, Dorey F, Rollins J, Amstutz HC. Ten-year experience at the University of California at Los Angeles Medical Center. J Bone Joint Surg Am. 1986;68:226-34.
7. EA Salvati RP Robinson SM Zeno BL Koslin BD Brause PDJ Wilson 1982 Infection rates after 3175 total hip and total knee replacements performed with and without a horizontal unidirectional filtered air-flow system J Bone Jt Surg Am 64 525 535 1:STN:280:DyaL387mslOjtg%3D%3D
8. MP Ginebra T Traykova JA Planell 2006 Calcium phosphate cements: competitive drug carriers for the musculoskeletal system? Biomaterials 27 10 2171 2177 10.1016/j.biomaterials.2005.11.023 1:CAS:528:DC%2BD2MXhtlWhsLfJ 16332349 (Pubitemid 41782020)
9. HW Buchholz RA Elson E Engelbrecht H Lodenkamper J Rottger A Siegel 1981 Management of deep infection of total hip replacement J Bone Jt Surg Br 63 342 353 (Pubitemid 11039510)
10. N Passuti F Gouin 2003 Antibiotic-loaded bone cement in orthopedic surgery Jt Bone Spine 70 3 169 174 10.1016/S1297-319X(03)00002-2 (Pubitemid 36753468)
11. Zalavras CG, Patzakis MJ, Holtom P. Local antibiotic therapy in the treatment of open fractures and osteomyelitis. Clin Orthop Relat Res. 2004;(427):86-93.
12. M Colilla M Manzano M Vallet-Regi 2008 Recent advances in ceramic implants as drug delivery systems for biomedical applications Int J Nanomed 3 4 403 414 1:CAS:528:DC%2BD1MXjtFGiurY%3D
13. JY Lee SH Nam SY Im YJ Park YM Lee YJ Seol, et al. 2002 Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials J Control Release 78 1-3 187 197 10.1016/S0168-3659(01)00498-9 1:CAS:528:DC%2BD3MXptlaitrg%3D 11772460 (Pubitemid 34081864)
14. JY Lee YJ Seol KH Kim YM Lee YJ Park IC Rhyu, et al. 2004 Transforming growth factor (TGF)-beta1 releasing tricalcium phosphate/chitosan microgranules as bone substitutes Pharm Res 21 10 1790 1796 10.1023/B:PHAM.0000045230.14287.73 1:CAS:528:DC%2BD2cXos1WqtL4%3D 15553224 (Pubitemid 39390090)
15. HW Kim JC Knowles HE Kim 2005 Hydroxyapatite porous scaffold engineered with biological polymer hybrid coating for antibiotic Vancomycin release J Mater Sci Mater Med 16 3 189 195 10.1007/s10856-005-6679-y 15744609 (Pubitemid 40386272)
16. BL Eppley M Reilly 1997 Degradation characteristics of PLLA-PGA bone fixation devices J Craniofac Surg 8 2 116 120 1:STN:280:DyaK1M3msVKrsA%3D%3D 10332278
17. O Bostman H Pihlajamaki 2000 Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review Biomaterials 21 24 2615 2621 10.1016/S0142-9612(00)00129-0 1:CAS:528:DC%2BD3cXmvFylsLs%3D 11071611
18. T Furukawa Y Matsusue T Yasunaga Y Nakagawa Y Okada Y Shikinami, et al. 2000 Histomorphometric study on high-strength hydroxyapatite/poly(L-lactide) composite rods for internal fixation of bone fractures J Biomed Mater Res 50 3 410 419 10.1002/(SICI)1097-4636(20000605)50:3<410::AID-JBM16>3.0.CO;2-Y 1:CAS:528:DC%2BD3cXit1Kmtr0%3D 10737884 (Pubitemid 30180734)
19. K Rezwan QZ Chen JJ Blaker AR Boccaccini 2006 Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering Biomaterials 27 18 3413 3431 10.1016/j.biomaterials.2006.01.039 1:CAS:528:DC%2BD28XisFCjtrw%3D 16504284
20. T Miyai A Ito G Tamazawa T Matsuno Y Sogo C Nakamura, et al. 2008 Antibiotic-loaded poly-ε-caprolactone and porous β-tricalcium phosphate composite for treating osteomyelitis Biomaterials 29 3 350 358 10.1016/j.biomaterials.2007.09.040 1:CAS:528:DC%2BD2sXht1yiurbL 17977596 (Pubitemid 350060982)
21. T Tuzuner I Uygur I Sencan U Haklar B Oktas D Ozdemir 2007 Elution characteristics and mechanical properties of calcium sulfate-loaded bone cement containing teicoplanin J Orthop Sci 12 2 170 177 10.1007/s00776-006-1107-9 1:CAS:528:DC%2BD2sXjsFygsbo%3D 17393273 (Pubitemid 46723684)
22. B Rai SH Teoh DW Hutmacher T Cao KH Ho 2005 Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2 Biomaterials 26 17 3739 3748 10.1016/j.biomaterials.2004.09.052 1:CAS:528:DC%2BD2cXhtFejsrnM 15621264 (Pubitemid 40038169)
23. LF Zhang R Sun L Xu J Du ZC Xiong HC Chen, et al. 2008 Hydrophilic poly (ethylene glycol) coating on PDLLA/BCP bone scaffold for drug delivery and cell culture Mater Sci Eng, C 28 1 141 149 10.1016/j.msec.2007.01.005 (Pubitemid 350297880)
24. J Schnieders U Gbureck R Thull T Kissel 2006 Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement Biomaterials 27 23 4239 4249 10.1016/j.biomaterials.2006.03.032 1:CAS:528:DC%2BD28XktVWrur8%3D 16620958 (Pubitemid 44294361)
25. PQ Ruhe OC Boerman FG Russel PH Spauwen AG Mikos JA Jansen 2005 Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo J Control Release 106 1-2 162 171 10.1016/j.jconrel.2005.04.018 1:CAS:528:DC%2BD2MXntlSiu7g%3D 15972241 (Pubitemid 41140091)
26. TJ Makinen M Veiranto P Lankinen N Moritz J Jalava P Tormala, et al. 2005 In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler J Antimicrob Chemother 56 6 1063 1068 10.1093/jac/dki366 16234335 (Pubitemid 43009821)
27. H Li J Chang 2005 Preparation, characterization and in vitro release of gentamicin from PHBV/wollastonite composite microspheres J Control Release 107 3 463 473 10.1016/j.jconrel.2005.05.019 1:CAS:528:DC%2BD2MXhtVCltLrN 16154657 (Pubitemid 41393355)
28. HW Kim EJ Lee IK Jun HE Kim JC Knowles 2005 Degradation and drug release of phosphate glass/polycaprolactone biological composites for hard-tissue regeneration J Biomed Mater Res B Appl Biomater 75 1 34 41 16001393
29. HW Kim JC Knowles HE Kim 2004 Hydroxyapatite/poly(epsilon-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery Biomaterials 25 7-8 1279 1287 10.1016/j.biomaterials.2003.07.003 1:CAS:528:DC%2BD3sXptFGrs7k%3D 14643602 (Pubitemid 37476205)
30. Y Zhang M Zhang 2002 Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release J Biomed Mater Res 62 3 378 386 10.1002/jbm.10312 1:CAS:528:DC%2BD38XntFOkur8%3D 12209923 (Pubitemid 35332201)
31. M Sivakumar K Panduranga Rao 2002 Preparation, characterization and in vitro release of gentamicin from coralline hydroxyapatite-gelatin composite microspheres Biomaterials 23 15 3175 3181 10.1016/S0142-9612(02)00066-2 1:CAS:528:DC%2BD38XjvVGisLo%3D 12102189 (Pubitemid 34522131)
32. D Arcos CV Ragel M Vallet-Regi 2001 Bioactivity in glass/PMMA composites used as drug delivery system Biomaterials 22 7 701 708 10.1016/S0142-9612(00) 00233-7 1:CAS:528:DC%2BD3MXhtFaksLg%3D 11246964 (Pubitemid 32114124)
33. CV Ragel M Vallet-Regi 2000 In vitro bioactivity and gentamicin release from glass-polymer-antibiotic composites J Biomed Mater Res 51 3 424 429 10.1002/1097-4636(20000905)51:3<424::AID-JBM17>3.0.CO;2-E 1:CAS:528:DC%2BD3cXkslagt7o%3D 10880085 (Pubitemid 30452146)
34. VC Amaro Martins G Goissis 2000 Nonstoichiometric hydroxyapatite-anionic collagen composite as support for the double sustained release of gentamicin and norfloxacin/ciprofloxacin Artif Organs 24 3 224 230 10.1046/j.1525-1594.2000. 06517.x 1:STN:280:DC%2BD3c3it12nug%3D%3D 10759646 (Pubitemid 30430694)
35. M Catauro MG Raucci D De Marco L Ambrosio 2006 Release kinetics of ampicillin, characterization and bioactivity of TiO2/PCL hybrid materials synthesized by sol-gel processing J Biomed Mater Res 77A 2 340 350 10.1002/jbm.a.30617 1:CAS:528:DC%2BD28Xjs1yrtbw%3D (Pubitemid 47233536)
36. M Catauro M Raucci G Ausanio 2008 Sol-gel processing of drug delivery zirconia/polycaprolactone hybrid materials J Mater Sci Mater Med 19 2 531 540 10.1007/s10856-007-3065-y 1:CAS:528:DC%2BD1cXhs1WktLc%3D 17619979 (Pubitemid 351244020)
37. T Abe M Sakane T Ikoma M Kobayashi S Nakamura N Ochiai 2008 Intraosseous delivery of paclitaxel-loaded hydroxyapatitealginate composite beads delaying paralysis caused by metastatic spine cancer in rats J Neurosurg 9 5 502 510
38. J Xiao Y Zhu Y Liu Y Zeng F Xu 2009 An asymmetric coating composed of gelatin and hydroxyapatite for the delivery of water insoluble drug J Mater Sci Mater Med 20 4 889 896 10.1007/s10856-008-3631-y 1:CAS:528:DC%2BD1MXit1OhtL8%3D 19020957
39. M Lin H Wang S Meng W Zhong Z Li R Cai, et al. 2007 Structure and release behavior of PMMA/silica composite drug delivery system J Pharm Sci 96 6 1518 1526 10.1002/jps.20809 1:CAS:528:DC%2BD2sXmt1Cis70%3D 17094137 (Pubitemid 46953767)
40. M Otsuka K Otsuka 2005 Bone regeneration by using drug delivery system technology and apatite intelligent materials J Hard Tissue Biol 14 2 261 262 10.2485/jhtb.14.261 1:CAS:528:DC%2BD28Xjs1Kntrs%3D
41. Gallant JE. Available from: http://prod.hopkins-abxguide.org/diagnosis/ bone-joint/osteomyelitis/osteomyelitis--chronic.html?contentInstanceId=255457. Accessed 25 July 2009
42. MR McClung P Geusens PD Miller H Zippel WG Bensen C Roux, et al. 2001 Effect of risedronate on the risk of hip fracture in elderly women. Hip intervention program study group N Engl J Med 344 5 333 340 10.1056/ NEJM200102013440503 1:CAS:528:DC%2BD3MXht1Wlu7g%3D 11172164 (Pubitemid 32107641)
43. S Harbarth SL Pestotnik JF Lloyd JP Burke MH Samore 2001 The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy Am J Med 111 528 534 10.1016/S0002-9343(01)00928-7 1:CAS:528:DC%2BD3MXot1OmurY%3D 11705428 (Pubitemid 33052350)
44. CY Hsieh HJ Hsieh HC Liu DM Wang LT Hou 2006 Fabrication and release behavior of a novel freeze-gelled chitosan/gamma-PGA scaffold as a carrier for rhBMP-2 Dent Mater 22 7 622 629 10.1016/j.dental.2005.05.012 1:CAS:528:DC%2BD28Xls1aqsbY%3D 16239024 (Pubitemid 43870113)
45. CA Fux JW Costerton PS Stewart P Stoodley 2005 Survival strategies of infectious biofilms Trends Microbiol 13 1 34 40 10.1016/j.tim.2004.11.010 1:CAS:528:DC%2BD2MXhvF2ntA%3D%3D 15639630 (Pubitemid 40082395)
46. G Mathew BP Hanson 2009 Global burden of trauma: need for effective fracture therapies Indian J Orthop 43 111 116 10.4103/0019-5413.50843 19838358
47. G Schmidmaier P Schwabe C Strobel B Wildemann 2008 Carrier systems and application of growth factors in orthopaedics Injury 39 Suppl 2 S37 S43 10.1016/S0020-1383(08)70014-7 18804572
48. BH Woo BF Fink R Page JA Schrier YW Jo G Jiang, et al. 2001 Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix Pharm Res 18 12 1747 1753 10.1023/A: 1013382832091 1:CAS:528:DC%2BD38XhvVantQ%3D%3D 11785696 (Pubitemid 34020432)
49. J Koort T Mäkinen E Suokas M Veiranto J Jalava J Knuuti, et al. 2005 Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus Antimicrob Agents Chemother 49 4 1502 1508 10.1128/AAC.49.4.1502-1508.2005 1:CAS:528:DC%2BD2MXjt1Gjsb4%3D 15793132 (Pubitemid 40463382)
50. S Padilla RP del Real M Vallet-Regi 2002 In vitro release of gentamicin from OHAp/PEMA/PMMA samples J Control Release 83 3 343 352 10.1016/S0168- 3659(02)00168-2 1:CAS:528:DC%2BD38XnvVequ7Y%3D 12387943 (Pubitemid 35223257)
51. A Ramila RP del Real R Marcos P Horcajada M Vallet-Regi 2003 Drug release and in vitro assays of bioactive polymer/glass mixtures J Sol Gel Sci Tech 26 1195 1198 10.1023/A:1020708203125 1:CAS:528:DC%2BD38XotFGhsbY%3D
52. Q Xu JT Czernuszka 2008 Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheres J Control Release 127 2 146 153 1:CAS:528:DC%2BD1cXkt1OrtLw%3D 18325617
53. X Niu Q Feng M Wang X Guo Q Zheng 2009 Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2 J Control Release 134 2 111 117 10.1016/j.jconrel. 2008.11.020 1:CAS:528:DC%2BD1MXisVGgsLg%3D 19100794
54. Y Wang X Wang K Wei N Zhao S Zhang J Chen 2007 Fabrication, characterization and long-term in vitro release of hydrophilic drug using PHBV/HA composite microspheres Mater Lett 61 4-5 1071 1076 10.1016/j.matlet. 2006.06.062 1:CAS:528:DC%2BD2sXltVygtg%3D%3D (Pubitemid 46054271)
55. ML Ho YC Fu GJ Wang HT Chen JK Chang TH Tsai, et al. 2008 Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite J Control Release 128 2 142 148 10.1016/j.jconrel.2008.02.012 1:CAS:528:DC%2BD1cXlvFKqt7Y%3D 18436324
56. JM Xue M Shi 2004 PLGA/mesoporous silica hybrid structure for controlled drug release J Control Release 98 2 209 217 10.1016/j.jconrel.2004.04.023 1:CAS:528:DC%2BD2cXlslGis7g%3D 15262413 (Pubitemid 38960669)
57. C Castro E Sanchez A Delgado I Soriano P Nunez M Baro, et al. 2003 Ciprofloxacin implants for bone infection. In vitro-in vivo characterization J Control Release 93 3 341 354 10.1016/j.jconrel.2003.09.004 1:CAS:528: DC%2BD3sXptlCmsLo%3D 14644584 (Pubitemid 37485956)
58. MB Yaylaoglu P Korkusuz U Ors F Korkusuz V Hasirci 1999 Development of a calcium phosphate-gelatin composite as a bone substitute and its use in drug release Biomaterials 20 8 711 719 10.1016/S0142-9612(98)00199-9 1:CAS:528:DyaK1MXis12nsLk%3D 10353654 (Pubitemid 29176700)
59. SS Kelpke KR Zinn LW Rue JA Thompson 2004 Site-specific delivery of acidic fibroblast growth factor stimulates angiogenic and osteogenic responses in vivo J Biomed Mater Res A 71 2 316 325 10.1002/jbm.a.30163 1:STN:280:DC%2BD2cvps1KqtQ%3D%3D 15376268 (Pubitemid 39362913)
60. M Vallet-Regi S Granado D Arcos M Gordo MV Cabanas CV Ragel, et al. 1998 Preparation, characterization, and in vitro release of ibuprofen from AI2O3/PLA/PMMA composites J Biomed Mater Res 39 3 423 428 10.1002/(SICI)1097- 4636(19980305)39:3<423::AID-JBM11>3.0.CO;2-B 1:CAS:528: DyaK1cXnsVOrtg%3D%3D 9468051 (Pubitemid 28063458)
61. D Rentería-Zamarrón DA Cortés-Hernández L Bretado-Aragón W Ortega-Lara 2009 Mechanical properties and apatite-forming ability of PMMA bone cements Mater Des 30 8 3318 3324
62. K Serbetci F Korkusuz N Hasirci 2000 Mechanical and thermal properties of hydroxyapatite-impregnated bone cement Turk J Med Sci 30 6 543 549 1:CAS:528:DC%2BD3cXptVClsrw%3D
63. VC Martins G Goissis AC Ribeiro E Marcantonio Jr MR Bet 1998 The controlled release of antibiotic by hydroxyapatite: anionic collagen composites Artif Organs 22 3 215 221 10.1046/j.1525-1594.1998.06004.x 1:CAS:528: DyaK1cXitlGisb4%3D 9527282 (Pubitemid 28117552)
64. Y Zhang M Zhang 2004 Cell growth and function on calcium phosphate reinforced chitosan scaffolds J Mater Sci Mater Med 15 3 255 260 10.1023/B:JMSM.0000015485.94665.25 1:CAS:528:DC%2BD2cXhtFShsrw%3D 15334997 (Pubitemid 38388823)
65. M Gravel T Gross R Vago M Tabrizian 2006 Responses of mesenchymal stem cell to chitosan-coralline composites microstructured using coralline as gas forming agent Biomaterials 27 9 1899 1906 10.1016/j.biomaterials.2005.10.020 1:CAS:528:DC%2BD2MXht12isLjN 16293302 (Pubitemid 41759484)
66. MH Ho PY Kuo HJ Hsieh TY Hsien LT Hou JY Lai, et al. 2004 Preparation of porous scaffolds by using freeze-extraction and freeze-gelation methods Biomaterials 25 1 129 138 10.1016/S0142-9612(03)00483-6 1:CAS:528: DC%2BD3sXot1Sktb4%3D 14580916 (Pubitemid 37324406)
67. V Maquet AR Boccaccini L Pravata I Notingher R Jerome 2004 Porous poly(alpha-hydroxyacid)/Bioglass composite scaffolds for bone tissue engineering. I: preparation and in vitro characterisation Biomaterials 25 18 4185 4194 10.1016/j.biomaterials.2003.10.082 1:CAS:528:DC%2BD2cXitlWqsbw%3D 15046908 (Pubitemid 38396765)
68. JS Lee JK Park 2003 Processing of porous ceramic spheres by pseudo-double-emulsion method Ceram Int 29 3 271 278 10.1016/S0272-8842(02) 00115-3 1:CAS:528:DC%2BD3sXht1Wntb8%3D
69. A Tampieri G Celotti E Landi M Montevecchi N Roveri A Bigi, et al. 2003 Porous phosphate-gelatine composite as bone graft with drug delivery function J Mater Sci Mater Med 14 7 623 627 10.1023/A:1024027125003 1:CAS:528: DC%2BD3sXktlamtb8%3D 15348425 (Pubitemid 36851214)
70. AC Jones CH Arns AP Sheppard DW Hutmacher BK Milthorpe MA Knackstedt 2007 Assessment of bone ingrowth into porous biomaterials using MICRO-CT Biomaterials 28 15 2491 2504 10.1016/j.biomaterials.2007.01.046 1:CAS:528:DC%2BD2sXis1CrsL4%3D 17335896 (Pubitemid 46365916)
71. RZ LeGeros 2008 Calcium phosphate-based osteoinductive materials Chem Rev 108 11 4742 4753 10.1021/cr800427g 19006399
72. R Schnettler HJ Pfefferle O Kilian C Heiss J Kreuter D Lommel, et al. 2005 Glycerol-l-lactide coating polymer leads to delay in bone ingrowth in hydroxyapatite implants J Control Release 106 1-2 154 161 10.1016/j.jconrel. 2005.04.011 1:CAS:528:DC%2BD2MXntlSiu7s%3D 15936110 (Pubitemid 41140090)
73. Biomechanics in Dentistry. Available from: http://www.feppd.org/ICB-Dent/ campus/biomechanics-in-dentistry/ldv-data/mech/basic-bone.htm. Accessed 25 July 2009
74. A Ratier I Gibson S Best M Freche J Lacout F Rodriguez 2001 Setting characteristics and mechanical behavior of a calcium phosphate bone cement containing tetracycline Biomaterials 22 897 901 10.1016/S0142-9612(00)00252-0 1:CAS:528:DC%2BD3MXitVOjurg%3D 11311008 (Pubitemid 32201440)
75. B Rai SH Teoh KH Ho 2005 An in vitro evaluation of PCL-TCP composites as delivery systems for platelet-rich plasma J Control Release 107 2 330 342 10.1016/j.jconrel.2005.07.002 1:CAS:528:DC%2BD2MXhtVShtr%2FI 16085332 (Pubitemid 41316295)
76. JC Knowles 2003 Phosphate based glasses for biomedical applications J Mater Chem 13 2395 2401 10.1039/b307119g 1:CAS:528:DC%2BD3sXnsVKrt78%3D
77. K Franks I Abrahams JC Knowles 2000 Development of soluble glasses for biomedical use. Part I: in vitro solubility measurement J Mater Sci Mater Med 11 10 609 614 10.1023/A:1008949527695 1:CAS:528:DC%2BD3cXnsFyju7w%3D 15348084 (Pubitemid 30757439)
78. T Niemelä 2005 Effect of [beta]-tricalcium phosphate addition on the in vitro degradation of self-reinforced poly-l, d-lactide Polym Degrad Stab 89 3 492 500 10.1016/j.polymdegradstab.2005.02.003 (Pubitemid 40794384)